Anders Tveita

6PUBLICATIONS
45CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cardiology (incl. cardiovascular diseases)Cardiovascular medicine and haematology not elsewhere classifiedMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 09, 2025
Targeting proteostasis in multiple myeloma through inhibition of LTK.

Thea Kristin Våtsveen, Mariaserena Giliberto, Valgerdur Bjornsdottir

|Jul 25, 2022
High Circulating Levels of the Homeostatic Chemokines CCL19 and CCL21 Predict Mortality and Disease Severity in COVID-19.

Anders Tveita, Sarah Louise Murphy, Jan Cato Holter

|Jul 12, 2021
Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial.

Andreas Barratt-Due, Inge Christoffer Olsen, Katerina Nezvalova-Henriksen

|Apr 26, 2020
Tankyrase inhibition sensitizes melanoma to PD-1 immune checkpoint blockade in syngeneic mouse models.

Jo Waaler, Line Mygland, Anders Tveita

|Dec 05, 2019
B cell receptor ligation induces display of V-region peptides on MHC class II molecules to T cells.

Peter Csaba Huszthy, Ramakrishna Prabhu Gopalakrishnan, Johanne Tracey Jacobsen

|Jan 30, 2019
Local Delivery of Ox40l, Cd80, and Cd86 mRNA Kindles Global Anticancer Immunity.

Ole Audun Werner Haabeth, Timothy R Blake, Colin J McKinlay

Pageof 1

Frequent Collaborators

2 joint publications

Ole Audun Werner Haabeth

2 joint publications

Anders Benjamin Kildal

1 joint publications

Robert M Waymouth

1 joint publications

Peter Csaba Huszthy